Sanjay Agarwala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sanjay Agarwala has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Mayank Vijayvargiya
Department of Orthopaedics and Traumatology, P D Hinduja Hospital and Medical Research Centre, Mumbai, Maharashtra, India
12 shared publications- Aditya Menon
P D Hinduja Hospital and Medical Research Centre, Mahim, Mumbai, India
5 shared publications - Mayank Vijayvargiya
Department of Orthopedics, P.D Hinduja Hospital and Medical Research Centre, Mumbai, India
5 shared publications Aditya Menon
Department of Orthopedics, P D Hinduja Hospital and Medical Research Centre, Mumbai, Maharashtra, India
3 shared publications- Mayank Vijayvargiya
Department of Orthopedics, P.D. Hinduja Hospital and Medical Research Centre, Mumbai, India
3 shared publications - Anshul Sobti
P.D. Hinduja National Hospital & Medical Research Centre, Veer Savarkar Marg, Mahim, Mumbai 400016, India
2 shared publications
Latest Publications
- 1 January 2026
- Published by Indian Orthopaedic Research Group in Journal of Orthopaedic Case Reports
- Vol. 16 (8) , 400-405
Painful Chondral Delamination in Early-Stage Osteonecrosis of the Femoral Head Precipitating Total Hip Arthroplasty
Introduction: Osteonecrosis of the femoral head (ONFH)/avascular necrosis of the femoral head (FH) is a debilitating clinical entity. Bisphosphonates (BPS) are beneficial for conservative/medical management, especially in the early stages. There is, however, a subset of patients with early ONFH who do not respond to BPS and continue to worsen clinically despite no radiological progression. This retrospective cross-sectional study offers a possible explanation for the inexplicable cause of the severe pain in patients with early ONFH from the gross pathological changes of the retrieved FH. Materials and Methods: A retrospective cross-sectional analysis was conducted on all patients who underwent THA for Early Ficat Arlet Stage Two by the senior surgeon following inadequate relief with BPS between August 2014 and February 2025. Gross intraoperative cartilage findings were graded as per Outerbridge Classification. Results: 116 patients (mean age 38.1 years) met the inclusion criteria. Cartilage changes observed were: softening in 37, partial thickness fissure in 30, full-thickness fissure in 17 and exposed subchondral bone in 32 FHs. Conclusion: Delamination of FH cartilage observed in retrieved FHs could explain the persistent pain in some patients with early ONFH unresponsive to medical therapy. Keywords: Osteonecrosis, total hip arthroplasty, chondral lesion, delamination, avascular necrosis of femoral head, cartilage loss, femoral head sparing procedure, femoral head replacement procedure.
- 1 January 2026
- Published by Indian Orthopaedic Research Group in Journal of Orthopaedic Case Reports
- Vol. 16 (8) , 400-405
Painful Chondral Delamination in Early-Stage Osteonecrosis of the Femoral Head Precipitating Total Hip Arthroplasty
Introduction: Osteonecrosis of the femoral head (ONFH)/avascular necrosis of the femoral head (FH) is a debilitating clinical entity. Bisphosphonates (BPS) are beneficial for conservative/medical management, especially in the early stages. There is, however, a subset of patients with early ONFH who do not respond to BPS and continue to worsen clinically despite no radiological progression. This retrospective cross-sectional study offers a possible explanation for the inexplicable cause of the severe pain in patients with early ONFH from the gross pathological changes of the retrieved FH. Materials and Methods: A retrospective cross-sectional analysis was conducted on all patients who underwent THA for Early Ficat Arlet Stage Two by the senior surgeon following inadequate relief with BPS between August 2014 and February 2025. Gross intraoperative cartilage findings were graded as per Outerbridge Classification. Results: 116 patients (mean age 38.1 years) met the inclusion criteria. Cartilage changes observed were: softening in 37, partial thickness fissure in 30, full-thickness fissure in 17 and exposed subchondral bone in 32 FHs. Conclusion: Delamination of FH cartilage observed in retrieved FHs could explain the persistent pain in some patients with early ONFH unresponsive to medical therapy. Keywords: Osteonecrosis, total hip arthroplasty, chondral lesion, delamination, avascular necrosis of femoral head, cartilage loss, femoral head sparing procedure, femoral head replacement procedure.
- Open Access
- 1 January 2025
- Published by Indian Orthopaedic Research Group in Journal of Orthopaedic Case Reports
- Vol. 15 (12) , 270-273
The Forced Drop Leg Test: A Novel Intraoperative Technique Enhancing Stability Assessments in Total Hip Arthroplasty
Introduction: Prosthetic instability remains a major challenge in total hip replacement (THR), which can result in dislocation, reduced mobility, and prosthetic loosening, requiring revision surgery. The forced drop leg test (FDLT) introduces a proactive approach by assessing hip stability under forced flexion, adduction, and rotation mimicking real-world dislocation mechanisms. Technique: Standard exposure and trial implants are utilized to evaluate fit and alignment. With the trial components in place, the leg is abducted to 30–40°, then forcefully dropped into a sterile pouch in front. The hip joint is subsequently examined for dislocation or subluxation. In case of any dislocation or subluxation, reassessment of the component size and position is necessary. Conclusion: Preliminary evidence suggests that FDLT enhances existing stability checks, although broader clinical validation and protocol standardization are necessary to confirm its effectiveness. Keywords: Total hip replacement, intraoperative stability, hip dislocation, forced drop leg test.
- 1 January 2025
- Published by Indian Orthopaedic Research Group in Journal of Orthopaedic Case Reports
- Vol. 15 (12) , 270-273
Open AccessThe Forced Drop Leg Test: A Novel Intraoperative Technique Enhancing Stability Assessments in Total Hip Arthroplasty
Introduction: Prosthetic instability remains a major challenge in total hip replacement (THR), which can result in dislocation, reduced mobility, and prosthetic loosening, requiring revision surgery. The forced drop leg test (FDLT) introduces a proactive approach by assessing hip stability under forced flexion, adduction, and rotation mimicking real-world dislocation mechanisms. Technique: Standard exposure and trial implants are utilized to evaluate fit and alignment. With the trial components in place, the leg is abducted to 30–40°, then forcefully dropped into a sterile pouch in front. The hip joint is subsequently examined for dislocation or subluxation. In case of any dislocation or subluxation, reassessment of the component size and position is necessary. Conclusion: Preliminary evidence suggests that FDLT enhances existing stability checks, although broader clinical validation and protocol standardization are necessary to confirm its effectiveness. Keywords: Total hip replacement, intraoperative stability, hip dislocation, forced drop leg test.
- Open Access
- 1 January 2025
- Published by Indian Orthopaedic Research Group in Journal of Orthopaedic Case Reports
- Vol. 15 (12) , 62-66
Novel Strategy for Incarcerated Broken Broach Retrieval in Total Hip Arthroplasty
Introduction: The goal of femoral component positioning in cementless total hip arthroplasty (THA) is accurate restoration of joint biomechanics and a press fit between the implant and the endosteal surface of the proximal femur. We present a case detailing an intraoperative broach fracture during THA and introduce a minimally invasive technique for broach removal. Case Report: A 45-year-old male with left hip osteoarthritis underwent left THA, and the final broach fractured during the extraction attempt. Given the hole in the proximal part of the broach’s shoulder, we created a cortical window near the proximal femur to expose the defect. The successful extraction was accomplished using a Kuntscher nail extractor. Notably, this technique resulted in no morbidity and eliminated the necessity for extending the approach or additional soft-tissue dissection. Conclusion: Notably, this technique resulted in no morbidity and eliminated the necessity for extending the approach or additional soft-tissue dissection. Surgeons performing THA must be prepared for unexpected challenges and possess the necessary skills to address complications. This report presents a case of femoral broach fracture during THA and describes an effective, economical, and safe solution to resolve the issue. Keywords: Broach fracture, hip, total hip arthroplasty, Kuntscher nail extractor
- 1 January 2025
- Published by Indian Orthopaedic Research Group in Journal of Orthopaedic Case Reports
- Vol. 15 (12) , 62-66
Open AccessNovel Strategy for Incarcerated Broken Broach Retrieval in Total Hip Arthroplasty
Introduction: The goal of femoral component positioning in cementless total hip arthroplasty (THA) is accurate restoration of joint biomechanics and a press fit between the implant and the endosteal surface of the proximal femur. We present a case detailing an intraoperative broach fracture during THA and introduce a minimally invasive technique for broach removal. Case Report: A 45-year-old male with left hip osteoarthritis underwent left THA, and the final broach fractured during the extraction attempt. Given the hole in the proximal part of the broach’s shoulder, we created a cortical window near the proximal femur to expose the defect. The successful extraction was accomplished using a Kuntscher nail extractor. Notably, this technique resulted in no morbidity and eliminated the necessity for extending the approach or additional soft-tissue dissection. Conclusion: Notably, this technique resulted in no morbidity and eliminated the necessity for extending the approach or additional soft-tissue dissection. Surgeons performing THA must be prepared for unexpected challenges and possess the necessary skills to address complications. This report presents a case of femoral broach fracture during THA and describes an effective, economical, and safe solution to resolve the issue. Keywords: Broach fracture, hip, total hip arthroplasty, Kuntscher nail extractor
- Open Access
- 8 October 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (10) , e258919
Achieving torsional stability of distal femur fractures through a single approach using 90–90 construct
Distal femoral fractures (DFFs) are frequently characterised by significant comminution, osteoporosis, high implant failure, insufficient fixation because of a shortened distal part, non-union, malunion, and poor outcome. Our report presents two cases treated with dual plating in a 90–90 construct to achieve torsional stability. DFF fixation by dual plating in a 90–90 configuration proved to be a superior fixation similar to 90–90 plating for distal humerus fracture, since 90–90 plate fixation had significantly greater torque to failure load and has more resistance to torsional loading. Two cases of distal femur non-union with implant failure were treated utilising a double plating. These non-union cases exhibited radiological healing and knee range of motion at a mean follow-up of 6 months. This technique offers a modified way of treating these difficult non-union cases through a single incision, providing mechanical stability conducive to fracture healing.
- 8 October 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (10) , e258919
Open AccessAchieving torsional stability of distal femur fractures through a single approach using 90–90 construct
Distal femoral fractures (DFFs) are frequently characterised by significant comminution, osteoporosis, high implant failure, insufficient fixation because of a shortened distal part, non-union, malunion, and poor outcome. Our report presents two cases treated with dual plating in a 90–90 construct to achieve torsional stability. DFF fixation by dual plating in a 90–90 configuration proved to be a superior fixation similar to 90–90 plating for distal humerus fracture, since 90–90 plate fixation had significantly greater torque to failure load and has more resistance to torsional loading. Two cases of distal femur non-union with implant failure were treated utilising a double plating. These non-union cases exhibited radiological healing and knee range of motion at a mean follow-up of 6 months. This technique offers a modified way of treating these difficult non-union cases through a single incision, providing mechanical stability conducive to fracture healing.
- Open Access
- 21 November 2022
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 7 (4)
Bisphosphonates for Post-COVID Osteonecrosis of the Femoral Head
Background: COVID-19 infection can cause long-term effects, cumulatively known as long COVID syndrome. One such sequela is osteonecrosis of the femoral head (also called avascular necrosis of the femoral head, or AVNFH). On the basis of our 20-year experience in using bisphosphonate therapy in the successful management of osteonecrosis, we conducted the present study to evaluate the efficacy of the therapy in the management of post-COVID osteonecrosis of the femoral head. In addition, we aimed to evaluate the cumulative dosage of corticosteroids and the duration between the commencement of corticosteroids and the development of osteonecrosis in COVID-19 survivors. Methods: This was a retrospective evaluation of 48 patients (88 hips) diagnosed with osteonecrosis of the femoral head at a tertiary care center after COVID-19 infection between September 2020 and May 2021. Patients received intravenous zoledronic acid (5 mg) at the initiation of therapy and oral alendronate (35 mg) twice weekly, and were followed for a minimum of 6 months. Clinical evaluation was conducted using a visual analog scale (VAS) for pain and the Harris hip score (HHS). Radiographic evaluation was performed to assess the progression of the disease and collapse of the femoral head. Results: At a mean follow-up of 10 months, 84 (95.5%) of the hips showed good clinical outcomes, and only 4 (4.5%) of the hips required surgical intervention. The mean VAS pain score and HHS improved at 6 weeks and steadily improved on subsequent follow-ups. In 16 (18%) of the 88 affected hips, radiographic progression was observed. The mean dose of corticosteroids administered to the patients to manage COVID-19 infection was 841.3 mg of prednisolone equivalents. The mean duration between the commencement of corticosteroid therapy and the development of osteonecrosis was 179 days. Conclusions: Post-COVID osteonecrosis appears to be more aggressive, with COVID-19 itself contributing to its etiopathogenesis in addition to corticosteroids. However, it can be diagnosed by magnetic resonance imaging (MRI) in symptomatic patients and then effectively treated medically, especially if detected in the early stages. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 21 November 2022
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 7 (4)
Open AccessBisphosphonates for Post-COVID Osteonecrosis of the Femoral Head
Background: COVID-19 infection can cause long-term effects, cumulatively known as long COVID syndrome. One such sequela is osteonecrosis of the femoral head (also called avascular necrosis of the femoral head, or AVNFH). On the basis of our 20-year experience in using bisphosphonate therapy in the successful management of osteonecrosis, we conducted the present study to evaluate the efficacy of the therapy in the management of post-COVID osteonecrosis of the femoral head. In addition, we aimed to evaluate the cumulative dosage of corticosteroids and the duration between the commencement of corticosteroids and the development of osteonecrosis in COVID-19 survivors. Methods: This was a retrospective evaluation of 48 patients (88 hips) diagnosed with osteonecrosis of the femoral head at a tertiary care center after COVID-19 infection between September 2020 and May 2021. Patients received intravenous zoledronic acid (5 mg) at the initiation of therapy and oral alendronate (35 mg) twice weekly, and were followed for a minimum of 6 months. Clinical evaluation was conducted using a visual analog scale (VAS) for pain and the Harris hip score (HHS). Radiographic evaluation was performed to assess the progression of the disease and collapse of the femoral head. Results: At a mean follow-up of 10 months, 84 (95.5%) of the hips showed good clinical outcomes, and only 4 (4.5%) of the hips required surgical intervention. The mean VAS pain score and HHS improved at 6 weeks and steadily improved on subsequent follow-ups. In 16 (18%) of the 88 affected hips, radiographic progression was observed. The mean dose of corticosteroids administered to the patients to manage COVID-19 infection was 841.3 mg of prednisolone equivalents. The mean duration between the commencement of corticosteroid therapy and the development of osteonecrosis was 179 days. Conclusions: Post-COVID osteonecrosis appears to be more aggressive, with COVID-19 itself contributing to its etiopathogenesis in addition to corticosteroids. However, it can be diagnosed by magnetic resonance imaging (MRI) in symptomatic patients and then effectively treated medically, especially if detected in the early stages. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
- Open Access
- 29 March 2022
- Published by BMJ in BMJ Case Reports
- Vol. 15 (3) , e248583
Secondary osteonecrosis of the knee as a part of long COVID-19 syndrome: a case series
COVID-19 infection affects different organ systems with long-term sequelae, which has been termed as long COVID-19 syndrome. To the best of our knowledge, osteonecrosis of the knee as a part of long COVID-19 syndrome has not been documented. Corticosteroids are being used extensively in moderate and severe cases of COVID-19. We report two cases who developed osteonecrosis of the knee after being treated for COVID-19 infection. In our case series, the mean cumulative dose of prednisolone was 1156.5 mg (900–1413 mg), which is less than the cumulative dose reported in literature for osteonecrosis of the knee. In our case series, the patients developed symptomatic osteonecrosis at a mean interval of 73 days after initiation of steroid therapy, with the earliest presenting at 25 days. Early diagnosis of osteonecrosis of the knee on high clinical suspicion by MRI would help in early intervention with bisphosphonate therapy.
- 29 March 2022
- Published by BMJ in BMJ Case Reports
- Vol. 15 (3) , e248583
Open AccessSecondary osteonecrosis of the knee as a part of long COVID-19 syndrome: a case series
COVID-19 infection affects different organ systems with long-term sequelae, which has been termed as long COVID-19 syndrome. To the best of our knowledge, osteonecrosis of the knee as a part of long COVID-19 syndrome has not been documented. Corticosteroids are being used extensively in moderate and severe cases of COVID-19. We report two cases who developed osteonecrosis of the knee after being treated for COVID-19 infection. In our case series, the mean cumulative dose of prednisolone was 1156.5 mg (900–1413 mg), which is less than the cumulative dose reported in literature for osteonecrosis of the knee. In our case series, the patients developed symptomatic osteonecrosis at a mean interval of 73 days after initiation of steroid therapy, with the earliest presenting at 25 days. Early diagnosis of osteonecrosis of the knee on high clinical suspicion by MRI would help in early intervention with bisphosphonate therapy.
- Open Access
- 19 October 2021
- Published by EDP Sciences in SICOT-J
- Vol. 7, 51
Predictive factors affecting long-term survivorship of ASR metal-on-metal total hip arthroplasty
Introduction: We present the outcome of 154 ASR (Articular Surface Replacement) hips performed at the P.D Hinduja Hospital and Medical Research Centre in terms of revision rate, metal ion levels, and factors affecting survivorship. Further, determined the importance of serial metal ion estimation over single value with poorly functioning arthroplasties. Methods: A retrospective study of 154 ASR arthroplasties (136 patients) performed from April 2005 till March 2010 was conducted. Ninety-seven patients were available for final analysis. All patients were assessed for symptoms, radiographs, blood metal (chromium and cobalt), metal artefact reduction sequence (MARS), magnetic resonance imaging (MRI), and computerized tomography (CT). Results: Female gender, smaller femoral head, patients with a rising level of metal ion levels were more likely to have revision surgery. However, abnormal acetabular inclination/anteversion was not associated with the occurrence of raised metal ion levels, ARMD (adverse reaction to metal debris) or revision surgery. Patients with raised metal ion levels were more likely to have periprosthetic lucency, ARMD, and revision surgery. Median metal levels increased initially for the first three years. Still, patients who required revision surgery continued to have a metal ion rise until the point when revision surgery was performed. In contrast, patients who had a fall in metal ion levels did not require revision. Conclusion: A single metal ion value is less predictive of failing arthroplasties; instead, a rising trend of metal ion levels can better delineate arthroplasties which will require revision. ASR hips whose blood ion levels fell after an initial rise and showed a declining trend did well.
- 19 October 2021
- Published by EDP Sciences in SICOT-J
- Vol. 7, 51
Open AccessPredictive factors affecting long-term survivorship of ASR metal-on-metal total hip arthroplasty
Introduction: We present the outcome of 154 ASR (Articular Surface Replacement) hips performed at the P.D Hinduja Hospital and Medical Research Centre in terms of revision rate, metal ion levels, and factors affecting survivorship. Further, determined the importance of serial metal ion estimation over single value with poorly functioning arthroplasties. Methods: A retrospective study of 154 ASR arthroplasties (136 patients) performed from April 2005 till March 2010 was conducted. Ninety-seven patients were available for final analysis. All patients were assessed for symptoms, radiographs, blood metal (chromium and cobalt), metal artefact reduction sequence (MARS), magnetic resonance imaging (MRI), and computerized tomography (CT). Results: Female gender, smaller femoral head, patients with a rising level of metal ion levels were more likely to have revision surgery. However, abnormal acetabular inclination/anteversion was not associated with the occurrence of raised metal ion levels, ARMD (adverse reaction to metal debris) or revision surgery. Patients with raised metal ion levels were more likely to have periprosthetic lucency, ARMD, and revision surgery. Median metal levels increased initially for the first three years. Still, patients who required revision surgery continued to have a metal ion rise until the point when revision surgery was performed. In contrast, patients who had a fall in metal ion levels did not require revision. Conclusion: A single metal ion value is less predictive of failing arthroplasties; instead, a rising trend of metal ion levels can better delineate arthroplasties which will require revision. ASR hips whose blood ion levels fell after an initial rise and showed a declining trend did well.
- Open Access
- 1 October 2021
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 6 (4)
A Paradigm Shift in Osteonecrosis Treatment with Bisphosphonates
Background: Bisphosphonates are proven to be effective in obviating the need for surgical intervention in osteonecrosis of the femoral head. However, the late onset of pain relief hampers compliance. We present the clinical and radiographic outcome of a combination therapy compared with alendronate-only therapy for the management of osteonecrosis of the femoral head. Methods: The data of patients diagnosed with osteonecrosis of the femoral head from January 2001 to January 2017 were retrospectively analyzed. The first group, the alendronate treatment group, comprised 432 hips (358 patients) diagnosed from January 2001 to January 2009 and treated with 10-mg oral alendronate daily for 3 years. The second group, the combination treatment group, comprised 442 hips (386 patients) diagnosed from February 2009 to January 2017 and treated with a combination therapy of 35-mg oral alendronate twice weekly and 5-mg intravenous zoledronic acid once annually for 3 years. Clinical assessment was performed using the Harris hip score, the visual analog scale (VAS) pain score, and the clinical failure rate. Radiographic assessment was performed for progression and collapse. Results: In the alendronate treatment group, at a mean follow-up of 129.6 months (range, 60 to 220 months), 74.5% did not require a surgical procedure, and, in the combination treatment group, at a mean follow-up of 69 months (range, 37 to 105 months), 88.9% did not require a surgical procedure. The clinical failure rate at 3 years was 4% for stage I, 11% for stage II, and 29% for stage III in the alendronate treatment group, and it was 5% for stage I, 9% for stage II, and 32% for stage III in the combination treatment group. Patients in the combination treatment group had a significantly better improvement in VAS score at 6 weeks (from 7.10 to 3.66) compared with patients in the alendronate treatment group (from 7.93 to 7.00). Conclusions: Our study shows that both oral alendronate-only therapy and bisphosphonate combination therapy retard the progression of disease, reduce the rate of collapse, and, hence, reduce the need for joint replacement surgery. However, bisphosphonate combination therapy offers earlier improvement in pain and functional scores compared with oral alendronate therapy only. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 1 October 2021
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 6 (4)
Open AccessA Paradigm Shift in Osteonecrosis Treatment with Bisphosphonates
Background: Bisphosphonates are proven to be effective in obviating the need for surgical intervention in osteonecrosis of the femoral head. However, the late onset of pain relief hampers compliance. We present the clinical and radiographic outcome of a combination therapy compared with alendronate-only therapy for the management of osteonecrosis of the femoral head. Methods: The data of patients diagnosed with osteonecrosis of the femoral head from January 2001 to January 2017 were retrospectively analyzed. The first group, the alendronate treatment group, comprised 432 hips (358 patients) diagnosed from January 2001 to January 2009 and treated with 10-mg oral alendronate daily for 3 years. The second group, the combination treatment group, comprised 442 hips (386 patients) diagnosed from February 2009 to January 2017 and treated with a combination therapy of 35-mg oral alendronate twice weekly and 5-mg intravenous zoledronic acid once annually for 3 years. Clinical assessment was performed using the Harris hip score, the visual analog scale (VAS) pain score, and the clinical failure rate. Radiographic assessment was performed for progression and collapse. Results: In the alendronate treatment group, at a mean follow-up of 129.6 months (range, 60 to 220 months), 74.5% did not require a surgical procedure, and, in the combination treatment group, at a mean follow-up of 69 months (range, 37 to 105 months), 88.9% did not require a surgical procedure. The clinical failure rate at 3 years was 4% for stage I, 11% for stage II, and 29% for stage III in the alendronate treatment group, and it was 5% for stage I, 9% for stage II, and 32% for stage III in the combination treatment group. Patients in the combination treatment group had a significantly better improvement in VAS score at 6 weeks (from 7.10 to 3.66) compared with patients in the alendronate treatment group (from 7.93 to 7.00). Conclusions: Our study shows that both oral alendronate-only therapy and bisphosphonate combination therapy retard the progression of disease, reduce the rate of collapse, and, hence, reduce the need for joint replacement surgery. However, bisphosphonate combination therapy offers earlier improvement in pain and functional scores compared with oral alendronate therapy only. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- Open Access
- 17 August 2021
- Published by EDP Sciences in SICOT-J
- Vol. 7, 42
Superior functional outcome with dual mobility THR as compared to conventional THR in fracture neck femur: a prospective cohort study
Introduction: Total Hip Replacement (THR) in displaced Fracture Neck of Femur (FNOF) is associated with higher dislocation rates. Conventional THR with a large femoral head and anterior approach has reduced the instability, but it remains higher than THR done for other aetiology. Recent studies have shown reduced dislocation rates with dual mobility THR (DMTHR) for FNOF; however, there is a lack of comparative research to show its superiority over conventional THR. Further, its role in the Asian subcontinent, where the patient requires sitting cross-legged or squatting, has not been studied. Methods: A prospective cohort study of 103 elderly patients with displaced FNOF with a minimum follow-up of 1-year. Fifty-two patients were operated on with DMTHR and fifty-one patients with conventional THR. Both the groups were matched in terms of demographic data, surgical approach, and postoperative protocol. Radiological and functional outcomes in terms of Harris Hip Score (HHS), Range of motion, Patient Reported Outcome Measures (PROM), and Dislocation rate were compared between the two groups. Results: Mean HHS of the DMTHR group was 76.37 at three months and 87.02 at the end of the 1-year postoperatively, which was significantly better than the conventional THR group 65.65 at three months and 72.96 at 1-year. The range of motion was significantly better in the DMTHR group than the conventional THR group. There was no significant difference in radiological outcomes and postoperative dislocation rate between the two groups. Conclusion: Dual mobility implants give better results than conventional implants for primary THA in elderly patients of displaced FNOF regarding better function and greater range of motion.
- 17 August 2021
- Published by EDP Sciences in SICOT-J
- Vol. 7, 42
Open AccessSuperior functional outcome with dual mobility THR as compared to conventional THR in fracture neck femur: a prospective cohort study
Introduction: Total Hip Replacement (THR) in displaced Fracture Neck of Femur (FNOF) is associated with higher dislocation rates. Conventional THR with a large femoral head and anterior approach has reduced the instability, but it remains higher than THR done for other aetiology. Recent studies have shown reduced dislocation rates with dual mobility THR (DMTHR) for FNOF; however, there is a lack of comparative research to show its superiority over conventional THR. Further, its role in the Asian subcontinent, where the patient requires sitting cross-legged or squatting, has not been studied. Methods: A prospective cohort study of 103 elderly patients with displaced FNOF with a minimum follow-up of 1-year. Fifty-two patients were operated on with DMTHR and fifty-one patients with conventional THR. Both the groups were matched in terms of demographic data, surgical approach, and postoperative protocol. Radiological and functional outcomes in terms of Harris Hip Score (HHS), Range of motion, Patient Reported Outcome Measures (PROM), and Dislocation rate were compared between the two groups. Results: Mean HHS of the DMTHR group was 76.37 at three months and 87.02 at the end of the 1-year postoperatively, which was significantly better than the conventional THR group 65.65 at three months and 72.96 at 1-year. The range of motion was significantly better in the DMTHR group than the conventional THR group. There was no significant difference in radiological outcomes and postoperative dislocation rate between the two groups. Conclusion: Dual mobility implants give better results than conventional implants for primary THA in elderly patients of displaced FNOF regarding better function and greater range of motion.
- Top Cited PapersOpen Access
- 2 July 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (7) , e242101
Avascular necrosis as a part of ‘long COVID-19’
‘Long COVID-19’ can affect different body systems. At present, avascular necrosis (AVN) as a sequalae of ‘long COVID-19’ has yet not been documented. By large-scale use of life-saving corticosteroids in COVID-19 cases, we anticipate that there will be a resurgence of AVN cases. We report a series of three cases in which patients developed AVN of the femoral head after being treated for COVID-19 infection. The mean dose of prednisolone used in these cases was 758 mg (400–1250 mg), which is less than the mean cumulative dose of around 2000 mg steroid, documented in the literature as causative for AVN. Patients were symptomatic and developed early AVN presentation at a mean of 58 days after COVID-19 diagnosis as compared with the literature which shows that it generally takes 6 months to 1 year to develop AVN post steroid exposure.
- 2 July 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (7) , e242101
Top Cited PapersOpen AccessAvascular necrosis as a part of ‘long COVID-19’
‘Long COVID-19’ can affect different body systems. At present, avascular necrosis (AVN) as a sequalae of ‘long COVID-19’ has yet not been documented. By large-scale use of life-saving corticosteroids in COVID-19 cases, we anticipate that there will be a resurgence of AVN cases. We report a series of three cases in which patients developed AVN of the femoral head after being treated for COVID-19 infection. The mean dose of prednisolone used in these cases was 758 mg (400–1250 mg), which is less than the mean cumulative dose of around 2000 mg steroid, documented in the literature as causative for AVN. Patients were symptomatic and developed early AVN presentation at a mean of 58 days after COVID-19 diagnosis as compared with the literature which shows that it generally takes 6 months to 1 year to develop AVN post steroid exposure.